Apathy is a highly prevalent, disabling and treatment resistant syndrome. It is defined as a quantitative reduction of goal-directed activity in comparison to the patient's previous level of in multiple dimensions including behavior/cognition, emotion and social interaction. It has been described in major depressive disorder, Alzheimer's disease, frontotemporal dementia, Parkinson's Disease, cerebrovascular disease, and vascular dementia, among others. This review will address the neuropsychology and associated neurobiological underpinnings of apathy in the above conditions, identify specific methods to assess apathy clinically, and review the literature on managing apathy across these various disorders.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077060 | PMC |
| http://dx.doi.org/10.9758/cpn.2021.19.2.181 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Social anxiety undermines prosocial behaviors when required effort.
Int J Clin Health Psychol
December 2024
Research Center of Mental Health Education, Faculty of Psychology, Southwest University, Chongqing, 400715, China.
Social anxiety impairs interpersonal relationships, which rely heavily on prosocial behaviors essential for healthy social interactions. The influence of social anxiety on the dynamics of helping others, through stages of prosocial choice stimulus presentation and effort, is not well understood. This study combines two experiments that integrate effort-based decision-making tasks with electroencephalography to distinguish between the choice stimulus presentation and effort phases of prosocial behavior.
View Article and Find Full Text PDFBiomarkers.
Alzheimers Dement
December 2024
Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Background: We explored the relationship of neuropsychiatric symptoms (assesses by NPI) and Alzheimer disease pathophysiology from blood AB42/40, GFAB, NFL, and pTau181. We also investigated if age and cognition were related to these neuropsychiatric symptoms.
Method: 222 subjects included 96 dementia, 66 MCI, and 60 normal controls (NC).
Biomarkers.
Alzheimers Dement
December 2024
Boston University Alzheimer's Disease Research Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Background: Traumatic encephalopathy syndrome (TES) is the proposed clinical syndrome of the neurodegenerative disease chronic traumatic encephalopathy (CTE). As part of the 2021 TES NINDS consensus diagnostic criteria, certainty levels of underlying CTE neuropathology can be determined (i.e.
View Article and Find Full Text PDFBackground: Neuropsychiatric symptoms (NPS) constitute a major challenge for patients with Alzheimer's disease (AD). We have recently demonstrated that in AD, overall NPS burden is significantly associated with patient function. However, few studies have examined the relationship between specific symptom clusters with neurological biomarkers.
View Article and Find Full Text PDFBiomarkers.
Alzheimers Dement
December 2024
Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada.
Background: Apathy in patients with Alzheimer's disease (AD) is associated with significant morbidity. We examined whether interactions between genetic variants related to neurotransmitter systems and regional brain atrophy are associated with apathy in patients with mild cognitive impairment (MCI) and AD.
Method: For 1162 participants in the Alzheimer's Disease Neuroimaging Initiative, including those with AD, MCI and cognitively normal individuals, a partial least squares correspondence analysis (PLS-CA) modeled interactions between single nucleotide polymorphisms (SNPs), structural whole-brain imaging variables, and apathy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!